{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:31:00Z","timestamp":1790875860019,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2022J01270"],"award-info":[{"award-number":["2022J01270"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303051"],"award-info":[{"award-number":["82303051"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272868"],"award-info":[{"award-number":["82272868"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bioorg.2025.109303","type":"journal-article","created":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T23:00:48Z","timestamp":1764543648000},"page":"109303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Gypenoside L inhibits oral squamous cell carcinoma progression by targeting the AKT signaling pathway"],"prefix":"10.1016","volume":"168","author":[{"given":"Dan-Ye","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Li","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Guang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Huan","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2025.109303_bb0005","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2025.109303_bb0010","first-page":"7","article-title":"The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)","author":"Cohen","year":"2019","journal-title":"J. ImmunoTher. Cancer"},{"key":"10.1016\/j.bioorg.2025.109303_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2019.03.031","article-title":"Phloretin loaded chitosan nanoparticles augments the pH-dependent mitochondrial-mediated intrinsic apoptosis in human oral cancer cells","volume":"130","author":"Mariadoss","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"Pt 2","key":"10.1016\/j.bioorg.2025.109303_bb0020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.semcancer.2018.01.008","article-title":"Head and neck squamous cell carcinoma: genomics and emerging biomarkers for immunomodulatory cancer treatments","volume":"52","author":"Solomon","year":"2018","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109303_bb0025","article-title":"Survival and prognostic factors in patients with oral squamous cell carcinoma","volume":"26","author":"Ferreira","year":"2021","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109303_bb0030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.archoralbio.2011.11.017","article-title":"Green tea: a promising natural product in oral health","volume":"57","author":"Narotzki","year":"2012","journal-title":"Arch. Oral Biol."},{"issue":"16","key":"10.1016\/j.bioorg.2025.109303_bb0035","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1080\/10408398.2018.1461607","article-title":"Pharmacological potential of methylxanthines: retrospective analysis and future expectations","volume":"59","author":"Monteiro","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.bioorg.2025.109303_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113574","article-title":"Triterpenoids from the genus Gynostemma: chemistry and pharmacological activities","volume":"268","author":"Nguyen","year":"2021","journal-title":"J. Ethnopharmacol."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109303_bb0045","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.bcp.2005.07.033","article-title":"A novel LXR-alpha activator identified from the natural product Gynostemma pentaphyllum","volume":"70","author":"Huang","year":"2005","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109303_bb0050","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1039\/D0FO00395F","article-title":"Jiaogulan tea (Gpostemma pentaphyllum) potentiates the antidiabetic effect of white tea via the AMPK and PI3K pathways in C57BL\/6 mice","volume":"11","author":"Xia","year":"2020","journal-title":"Food Funct."},{"issue":"Pt 1","key":"10.1016\/j.bioorg.2025.109303_bb0055","article-title":"Saponins derived from Gynostemma pentaphyllum regulate triglyceride and cholesterol metabolism and the mechanisms: a review","volume":"319","author":"Xie","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109303_bb0060","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/09168451.2014.882751","article-title":"Determination by UPLC-MS of four dammarane-type saponins from heat-processed Gynostemma pentaphyllum","volume":"78","author":"Wu","year":"2014","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109303_bb0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1534735411403306","article-title":"Gypenosides suppress growth of human oral cancer SAS cells in vitro and in a murine xenograft model: the role of apoptosis mediated by caspase-dependent and caspase-independent pathways","volume":"11","author":"Lu","year":"2012","journal-title":"Integr. Cancer Ther."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109303_bb0070","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1111\/jcmm.13743","article-title":"Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation","volume":"22","author":"Zhang","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"06","key":"10.1016\/j.bioorg.2025.109303_bb0075","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1142\/S0192415X18500696","article-title":"Gypenoside UL4-rich Gynostemma pentaphyllum extract exerts a hepatoprotective effect on diet-induced nonalcoholic fatty liver disease","volume":"46","author":"Bae","year":"2018","journal-title":"Am. J. Chin. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109303_bb0080","article-title":"Chemical constituents from a Gynostemma laxum and their antioxidant and neuroprotective activities","volume":"12","author":"Seo","year":"2017","journal-title":"Chinese Med. (United Kingdom)"},{"key":"10.1016\/j.bioorg.2025.109303_bb0085","article-title":"Gypenoside L and Gypenoside LI inhibit proliferation in renal cell carcinoma via regulation of the MAPK and arachidonic acid metabolism pathways","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109303_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107539","article-title":"Gypenoside L inhibits hepatocellular carcinoma by targeting the SREBP2-HMGCS1 axis and enhancing immune response","volume":"150","author":"Xiao","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109303_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24061054","article-title":"Gypenoside L inhibits proliferation of liver and Esophageal Cancer cells by inducing senescence","volume":"24","author":"Ma","year":"2019","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109303_bb0100","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1021\/acs.jafc.5b05668","article-title":"Gypenoside L, isolated from Gynostemma pentaphyllum, induces cytoplasmic vacuolation death in hepatocellular carcinoma cells through reactive-oxygen-species-mediated unfolded protein response","volume":"64","author":"Zheng","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2025.109303_bb0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jep.2018.03.012","article-title":"The inhibitory effect of gypenoside stereoisomers, gypenoside L and gypenoside LI, isolated from Gynostemma pentaphyllum on the growth of human lung cancer A549 cells","volume":"219","author":"Xing","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"W1","key":"10.1016\/j.bioorg.2025.109303_bb0110","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109303_bb0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41420-024-01833-7","article-title":"IL-8 activates fibroblasts to promote the invasion of HNSCC cells via STAT3-MMP1","volume":"10","author":"Chen","year":"2024","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109303_bb0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12885-020-6521-4","article-title":"Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma","volume":"20","author":"Yuan","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bioorg.2025.109303_bb0125","article-title":"Network pharmacology: a new approach for chinese herbal medicine research","volume":"2013","author":"Zhang","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109303_bb0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jep.2013.07.001","article-title":"Systems pharmacology strategies for drug discovery and combination with applications to cardiovascular diseases","volume":"151","author":"Li","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioorg.2025.109303_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102875","article-title":"Corrigendum to \u2018clinical and genetic landscape of treatment naive cervical cancer: alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome\u2019","volume":"57","author":"Scholl","year":"2020","journal-title":"EBioMedicine"},{"issue":"13","key":"10.1016\/j.bioorg.2025.109303_bb0140","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1158\/0008-5472.CAN-09-4476","article-title":"The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy","volume":"70","author":"Al-Saffar","year":"2010","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109303_bb0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0960-9822(06)00122-9","article-title":"Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha","volume":"7","author":"Alessi","year":"1997","journal-title":"Curr. Biol."},{"issue":"49","key":"10.1016\/j.bioorg.2025.109303_bb0150","doi-asserted-by":"crossref","first-page":"32377","DOI":"10.1074\/jbc.273.49.32377","article-title":"CREB is a regulatory target for the protein kinase Akt\/PKB","volume":"273","author":"Du","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109303_bb0155","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0960-9822(99)80265-6","article-title":"Induction of NF-kappaB by the Akt\/PKB kinase","volume":"9","author":"Kane","year":"1999","journal-title":"Curr. Biol."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109303_bb0160","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bbamcr.2010.04.005","article-title":"The emerging role of the phosphatidylinositol 3-kinase\/Akt\/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis","volume":"1803","author":"Martelli","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"5338","key":"10.1016\/j.bioorg.2025.109303_bb0165","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.278.5338.687","article-title":"Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt","volume":"278","author":"del Peso","year":"1997","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109303_bb0170","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1021\/acs.jafc.7b05305","article-title":"Akt serine\/threonine kinase 1 regulates de novo fatty acid synthesis through the mammalian target of rapamycin\/sterol regulatory element binding protein 1 Axis in dairy goat mammary epithelial cells","volume":"66","author":"Zhang","year":"2018","journal-title":"J. Agric. Food Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109303_bb0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1021\/acsmedchemlett.9b00548","article-title":"Spotlight on AKT: current therapeutic challenges","volume":"11","author":"Landel","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109303_bb0180","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/bcp.13021","article-title":"AKT in cancer: new molecular insights and advances in drug development","volume":"82","author":"Mundi","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"35","key":"10.1016\/j.bioorg.2025.109303_bb0185","doi-asserted-by":"crossref","first-page":"10313","DOI":"10.1002\/anie.201502142","article-title":"Covalent-allosteric kinase inhibitors","volume":"54","author":"Weisner","year":"2015","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109303_bb0190","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s13046-024-03207-4","article-title":"AKT kinases as therapeutic targets","volume":"43","author":"Hassan","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109303_bb0195","first-page":"1205","article-title":"Clinical pharmacokinetics of oxaliplatin: a critical review","volume":"6","author":"Graham","year":"2000","journal-title":"Clin. Cancer Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T09:53:52Z","timestamp":1767693232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825011836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":39,"alternative-id":["S0045206825011836"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109303","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gypenoside L inhibits oral squamous cell carcinoma progression by targeting the AKT signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109303","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109303"}}